In this study, the purified cucurbitacins were used to treat nucleophosmin (NPM)-mutated AML and other hematological cancer cell lines in order to examine their effects on viability, apoptosis, and cell cycle progression. The gene discussed is NPM1; the disease is hematopoietic and lymphoid cell neoplasm.